日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS)

纳武利尤单抗联合低剂量伊匹木单抗治疗高突变 HER2 阴性转移性乳腺癌:一项 II 期试验 (NIMBUS)

Barroso-Sousa, Romualdo; Zanudo, Jorge Gomez Tejeda; Li, Tianyu; Reddy, Sangeetha M; Emens, Leisha A; Kuntz, Thomas M; Silva, Carolina Alves Costa; AlDubayan, Saud H; Chu, Hoyin; Overmoyer, Beth; Lange, Paulina; DiLullo, Molly K; Montesion, Meagan; Kasparian, Julie; Hughes, Melissa E; Attaya, Victoria; Basta, Ameer; Lin, Nancy U; Tayob, Nabihah; Jeselsohn, Rinath; Mittendorf, Elizabeth A; Tolaney, Sara M

Clinicogenomic Characterization of Inflammatory Breast Cancer

炎性乳腺癌的临床基因组学特征分析

Priedigkeit, Nolan; Harrison, Beth; Shue, Robert; Hughes, Melissa E; Li, Yvonne; Lebrón-Torres, Alinés; Kirkner, Gregory J; Spurr, Liam F; Remolano, Marie Claire; Strauss, Sarah; Files, Janet; Feeney, Anne-Marie; Grant, Libby; Mohammed-Abreu, Ayesha; Garrido-Castro, Ana; Barroso-Sousa, Romualdo; Bychkovsky, Brittany; Nakhlis, Faina; Bellon, Jennifer R; King, Tari A; Winer, Eric P; Lindeman, Neal; Johnson, Bruce E; Sholl, Lynette; Dillon, Deborah; Overmoyer, Beth; Tolaney, Sara M; Cherniack, Andrew D; Lin, Nancy U; Lynce, Filipa

HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers

HER2阳性炎性乳腺癌中的HER2DX:相关性分析及与非炎性乳腺癌的比较分析

Lynce, F; Martínez-Sáez, O; Walbaum, B; Brasó-Maristany, F; Waks, A G; Villagrasa, P; Villacampa Javierre, G; Sanfeliu, E; Galván, P; Paré, L; Anderson, L M; Perou, C M; Parker, J S; Vivancos, A; DiLullo, M K; Pernas, S; Winer, E P; Overmoyer, B; Mittendorf, E A; Bueno-Muiño, C; Martín, M; Prat, A; Tolaney, S M

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score

建立多机构数据集以验证一种新型炎症性乳腺癌诊断评分

Lynce, Filipa; Niman, Samuel M; Kai, Megumi; Ryan, Sean; Troll, Elizabeth; Li, Li; Miller, Kathy D; Jagsi, Reshma; Mason, Ginny; Overmoyer, Beth A; Le-Petross, H T Carisa; Nakhlis, Faina; Krishnamurthy, Savitri; Harrison, Beth T; Sun, Susie X; Yeh, Eren D; Bellon, Jennifer R; Warren, Laura E; Stauder, Michael C; Regan, Meredith M; Woodward, Wendy A

Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study

艾立布林、多柔比星和环磷酰胺新辅助治疗HER2阴性炎性乳腺癌患者的II期研究

Fanucci, Kristina; Yeh, Eren D; Shi, Ruichao; Qin, Lei; Bay, Camden P; DiLullo, Molly; Patel, Ashka; Moore, McKenna; Herbert, Zachary T; Harrison, Beth T; Nakhlis, Faina; Bellon, Jennifer; Warren, Laura; Guerriero, Jennifer L; Tolaney, Sara M; Regan, Meredith; Overmoyer, Beth; Van Laere, Steven; Lynce, Filipa

Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapies

类器官可评估的临床生物标志物可预测药物反应并指导新的乳腺癌治疗

Bui, Tam Binh V; Wolf, Denise M; Bruck, Michael C; Moore, Kaitlin; Lien, Jessica; Choi, Sarah D W; Warhadpande, Shruti; Parizadeh, Amirabbas; Dillon, Deborah; Overmoyer, Beth; Lynce, Filipa; Nijman, Isaac J; Burgering, Boudewijn M T; Harris, Isaac S; Esserman, Laura J; Veer, Laura J van 't; Rosenbluth, Jennifer M

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

依西美坦联合依维莫司和帕博西尼治疗转移性乳腺癌:I/II期试验中的临床反应和基因组/转录组耐药性决定因素

Gómez Tejeda Zañudo, Jorge; Barroso-Sousa, Romualdo; Jain, Esha; Jin, Qingchun; Li, Tianyu; Buendia-Buendia, Jorge E; Pereslete, Alyssa; Abravanel, Daniel L; Ferreira, Arlindo R; Wrabel, Eileen; Helvie, Karla; Hughes, Melissa E; Partridge, Ann H; Overmoyer, Beth; Lin, Nancy U; Tayob, Nabihah; Tolaney, Sara M; Wagle, Nikhil

Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance

脑转移瘤内异常的血管结构和功能与帕博利珠单抗耐药性相关。

Kim, Albert E; Lou, Kevin W; Giobbie-Hurder, Anita; Chang, Ken; Gidwani, Mishka; Hoebel, Katharina; Patel, Jay B; Cleveland, Mason C; Singh, Praveer; Bridge, Christopher P; Ahmed, Syed Rakin; Bearce, Benjamin A; Liu, William; Fuster-Garcia, Elies; Lee, Eudocia Q; Lin, Nancy U; Overmoyer, Beth; Wen, Patrick Y; Nayak, Lakshmi; Cohen, Justine V; Dietrich, Jorg; Eichler, April; Heist, Rebecca; Krop, Ian; Lawrence, Donald; Ligibel, Jennifer; Tolaney, Sara; Mayer, Erica; Winer, Eric; Perrino, Carmen M; Summers, Elizabeth J; Mahar, Maura; Oh, Kevin; Shih, Helen A; Cahill, Daniel P; Rosen, Bruce R; Yen, Yi-Fen; Kalpathy-Cramer, Jayashree; Martinez-Lage, Maria; Sullivan, Ryan J; Brastianos, Priscilla K; Emblem, Kyrre E; Gerstner, Elizabeth R

TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer

TBCRC 039:一项关于术前使用鲁索替尼联合或不联合紫杉醇治疗三阴性炎性乳腺癌的II期研究

Lynce, Filipa; Stevens, Laura E; Li, Zheqi; Brock, Jane E; Gulvady, Anushree; Huang, Ying; Nakhlis, Faina; Patel, Ashka; Force, Jeremy M; Haddad, Tufia C; Ueno, Naoto; Stearns, Vered; Wolff, Antonio C; Clark, Amy S; Bellon, Jennifer R; Richardson, Edward T; Balko, Justin M; Krop, Ian E; Winer, Eric P; Lange, Paulina; Hwang, E Shelley; King, Tari A; Tolaney, Sara M; Thompson, Alastair; Gupta, Gaorav P; Mittendorf, Elizabeth A; Regan, Meredith M; Overmoyer, Beth; Polyak, Kornelia

Clinicogenomic characterization of inflammatory breast cancer

炎性乳腺癌的临床基因组学特征

Priedigkeit, Nolan; Harrison, Beth; Shue, Robert; Hughes, Melissa; Li, Yvonne; Kirkner, Gregory J; Spurr, Liam F; Remolano, Marie Claire; Strauss, Sarah; Files, Janet; Feeney, Anne-Marie; Grant, Libby; Mohammed-Abreu, Ayesha; Garrido-Castro, Ana; Sousa, Romualdo Barroso; Bychkovsky, Brittany; Nakhlis, Faina; Bellon, Jennifer R; King, Tari A; Winer, Eric P; Lindeman, Neal; Johnson, Bruce E; Sholl, Lynette; Dillon, Deborah; Overmoyer, Beth; Tolaney, Sara M; Cherniack, Andrew; Lin, Nancy U; Lynce, Filipa